Literature DB >> 12671539

Study of completeness of registration at the Estonian cancer registry.

K Lang1, M Mägi, T Aareleid.   

Abstract

Every cancer registry should be able to quantify the level of completeness of registration. The current study describes a routine quality control procedure in the Estonian Cancer Registry (ECR) for assessing the completeness of registration. The registry's database was compared with the databases of the Tartu University Lung Clinic and the Maarjamõisa Hospital of the Tartu University Clinics, and active retrieval to obtain missing cancer cases diagnosed in 1998 was carried out. The overall completeness of case ascertainment based on this study was 90.8%. As a result of this procedure, 67 cases of malignant neoplasms (1.1% of the total number of incident cancer cases for 1998) and 11 cases of other reportable neoplasms were detected and recorded at the ECR. Cancers of the lung, thyroid gland and prostate were most frequently under-notified. For these sites, the number of cancer cases for 1998 for Estonia as a whole increased 2.6%, 11.8% and 2.2%, respectively. To conclude, the existence of electronic databases is a positive development, but cancer registrars still need to employ labour-intensive methods to validate diagnostic codes and to decide whether to include in the ECR cases found by active retrieval. Based on the findings of our study, which is the first one of its kind in Estonia, the completeness of cancer reporting varied by cancer site, and it appeared to be a substantial concern for several sites.

Entities:  

Mesh:

Year:  2003        PMID: 12671539     DOI: 10.1097/00008469-200304000-00009

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  3 in total

1.  Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial.

Authors:  Piret Veerus; Krista Fischer; Matti Hakama; Elina Hemminki
Journal:  BMC Med Res Methodol       Date:  2012-04-04       Impact factor: 4.615

2.  Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.

Authors:  A Gentry-Maharaj; E-O Fourkala; M Burnell; A Ryan; S Apostolidou; M Habib; A Sharma; M Parmar; I Jacobs; U Menon
Journal:  Br J Cancer       Date:  2013-10-15       Impact factor: 7.640

3.  Data coverage of a cancer registry in southern Iran before and after implementation of a population-based reporting system: a 10-year trend study.

Authors:  Kamran Bagheri Lankarani; Zahra Khosravizadegan; Abbas Rezaianzadeh; Behnam Honarvar; Mohsen Moghadami; Hossein Faramarzi; Mojtaba Mahmoodi; Mahin Farahmand; Seyed Masoom Masoompour; Bahman Nazemzadegan
Journal:  BMC Health Serv Res       Date:  2013-05-06       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.